Drug enforcement officials increased the limit on US production of ADHD drugs Ritalin and Concerta, along with their generic versions, amid nationwide shortages of the medications. The Drug Enforcement Administration allows manufacturing of 53.3 million grams this year of the active ingredient in the drugs, methylphenidate, according to a public notice filed Friday. The earlier limit had been 41.8 million grams, according to the notice.